In this episode of Med Tech Talks, Robert Klupacs is joined by Scott Kirkland, CEO and Managing Director of EMVision Medical Devices.

EMVision (ASX:EMV) is an ASX listed, Australian med tech company focused on developing portable brain imaging devices using electromagnetic (EM) technology. It was spun out of University of Queensland in 2017 and had its IPO in late-2018.

EMVision’s primary product is a portable scanner designed to quickly and non-invasively detect and monitor neurological conditions like stroke.

Unlike traditional imaging methods such as CT or MRI, EMVision’s technology allows for bedside or on-the-go imaging, which can be particularly useful in emergency settings or in rural and remote locations to improve healthcare access.

Scott has a wealth of experience in the emerging tech both here and overseas, having previously been Head of Client Sales at Quantcast, a US-based technology company. He is also a member of the Australian Institute of Company Directors.

In this episode you will hear about:

How EMVision is using ultra high frequency radio signals to differentiate stroke types, with the aim of speeding up diagnosis and treatment particularly within the first hour post-onset of a stroke
Findings from the 300-patient trial* conducted in Australia, and the company’s plans for a pivotal US trial
Learnings from EMVision’s capital raising, which led to a AUD$15M investment from Keysight Technologies
The importance for startups to build strategic relationships early on and to utilise finite resources efficiently
Scott’s advice for budding entrepreneurs and those seeking mentorship.

Learn more about Scott Kirkland and EMVision Medical Devices.

*EMVision released EMView study data subsequent to this recording, see ASX release ‘Algorithms deliver excellent results in EMView study’ 12th Nov.

Updated version 05/08/22

Flora Lichtman

The AI-powered Podcast Player